Ignaczak Stephen MD - Newark, New York 14513

Ignaczak Stephen MD is categorized under Doctors in Newark, NY .

Business Name: Ignaczak Stephen MD
Contact Person: Stephen Ignaczak,
Address: 1200 Driving Park Avenue, Newark, New York 14513
Phone Number: (315) 462-1472
Website Address: flhocancercare.biz
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Toner Kenneth MD - Newark, NY 14513
Lovier John A MD - Newark, NY 14513
Reed Ronald R MD - Newark, NY 14513
Advano Deepak MD - Newark, NY 14513
Avanzato Cheryl MD - Newark, NY 14513
Pulvino A Thomas MD - Newark, NY 14513
Simmons Warren B MD - Newark, NY 14513
Chang Hwang-Nam MD - Newark, NY 14513
Sharma Neelam MD - Newark, NY 14513
Medeiros Lori MD - Newark, NY 14513
Mann Stephanie MD - Newark, NY 14513
Schabel Scott L MD - Newark, NY 14513
Brown Christopher MD - Newark, NY 14513
Andreitchouk Alexandra MD - Newark, NY 14513
Women's Center - Newark, NY 14513
Ray John S MD - Newark, NY 14513
Fink Jeffrey A MD - Newark, NY 14513
Davenport Mark S MD - Newark, NY 14513
Heeb Gregory T MD - Newark, NY 14513
Soliman Adel B MD - Newark, NY 14513

The company Ignaczak Stephen MD provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Ignaczak Stephen MD, and the business now earns $500.000 to $999.999 per annum.

Ignaczak Stephen MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Ignaczak Stephen MD, please call Stephen Ignaczak, with the phone number (315) 462-1472 or visit its single location at 1200 Driving Park Avenue in Newark, New York 14513.

The location of the single location can also be found using the coordinates 43.060025,-77.099455. Read more details about this business on the webpage flhocancercare.biz or follow the company’s social media accounts, on Twitter and on Facebook.